Why the study?
Does carvedilol reduce mortality and arrhythmias in patients with left ventricular dysfunction?
Does carvedilol reduce mortality and arrhythmias in patients with left ventricular dysfunction?
Carvedilol has important antiarrhythmic properties that contribute to reduced mortality and sudden cardiac death in patients with left ventricular dysfunction.
No takes yet. Share an insight, caveat, or question.
Supports carvedilol plus ACEI in LV dysfunction; leaves open need for prospective RCTs to confirm antiarrhythmic effects.
Naccarelli et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: